Baxter to buy bone graft developer for $300 million

Big win for Biologics startups…..and a big win for M&A in Orthopedics in this climate.

Baxter announced that it had acquired Apatech for $330M ($240M upfront plus $90M in earnouts when certain milestones are met).   Apatech is a manufacturer of synthetic bone repair materials, operations in London, England, Foxborough, Massachusetts, USA and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in over 20 countries around the world.

ChicagoBreakingNews… http://ow.ly/1dios

Baxter Press Release…  http://ow.ly/1di4V

Apatech website…   http://www.apatech.com/

Uncategorized